...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Next-Generation Sequencing Reveals a Controlled Immune Response to Zaire Ebola Virus Challenge in Cynomolgus Macaques Immunized with Vesicular Stomatitis Virus Expressing Zaire Ebola Virus Glycoprotein (VSV Delta G/EBOVgp)
【24h】

Next-Generation Sequencing Reveals a Controlled Immune Response to Zaire Ebola Virus Challenge in Cynomolgus Macaques Immunized with Vesicular Stomatitis Virus Expressing Zaire Ebola Virus Glycoprotein (VSV Delta G/EBOVgp)

机译:下一代测序揭示了在用囊泡猕猴中对Zaire Ebola病毒挑战的受控反应,该猕猴用表达Zaire Ebola病毒糖蛋白(VSV Delta g/ebovgp)的囊泡口腔炎病毒免疫了。

获取原文
获取原文并翻译 | 示例
           

摘要

Vesicular stomatitis virus expressing Zaire Ebola virus (EBOV) glycoprotein (VSV Delta G/EBOVgp) could be used as a vaccine to meet the 2014 Ebola virus outbreak. To characterize the host response to this vaccine, we used mRNA sequencing to analyze peripheral blood mononuclear cells (PBMCs) from cynomolgus macaques after VSV Delta G/EBOVgp immunization and subsequent EBOV challenge. We found a controlled transcriptional response that transitioned to immune regulation as the EBOV was cleared. This observation supports the safety of the vaccine.
机译:表达Zaire Ebola病毒(EBOV)糖蛋白(VSV Delta G/EBOVGP)的囊泡口腔炎病毒可用作满足2014年埃博拉病毒暴发的疫苗。 为了表征宿主对这种疫苗的反应,我们使用mRNA测序分析了VSV Delta G/eBOVGP免疫和随后的EBOV挑战后,分析了Cynomolgus猕猴的外周血单核细胞(PBMC)。 我们发现在清除EBOV时过渡到免疫调节的受控转录响应。 该观察结果支持疫苗的安全性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号